ELAN News and Press, Elanco Animal Health Incorporated From 09/05/23

Elanco Animal Health Incorporated (NYSE: ELAN) will attend the Morgan Stanley 21st Annual Global Healthcare Conference on Monday, September 11, 2023 and Tuesday, September 12, 2023. Jeff Simmons, president and CEO, will participate in a fireside chat on Monday at 4:15 p.m. ET. A live audio we...

2023-08-28 23:45:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2023-08-07 14:30:34 ET Image source: The Motley Fool. Elanco Animal Health (NYSE: ELAN) Q2 2023 Earnings Call Aug 07, 2023 , 8:00 a.m. ET Operator Continue reading For further details see: Elanco Animal Health (ELAN) Q2 2023 Earnings Call...

2023-08-07 13:31:08 ET Elanco Animal Health Incorporated (ELAN) Q2 2023 Earnings Conference Call August 07, 2023, 08:00 AM ET Company Participants Katy Grissom - Head of Investor Relations Jeff Simmons - President and Chief Executive Officer Todd Young - Chief Fi...

2023-08-07 08:47:46 ET More on Elanco Elanco Animal Health Incorporated 2023 Q2 - Results - Earnings Call Presentation Elanco Animal Health: Seems Like A Decent Bet Right Now Elanco Animal Health: Robust Results Overshadowed By Persisting Challenges Elanco ga...

2023-08-07 08:34:22 ET Missfresh ( MF ) +51% a nnounces Entry into Share Transfer Agreement. Sequans Communications  ( SQNS ) +31% Q2 earnings call release Tabula Rasa HealthCare ( TRHC ) +30% Reports Second Quarter 2023 Financial Results. ...

2023-08-07 06:37:46 ET Elanco press release ( NYSE: ELAN ): Q2 Non-GAAP EPS of $0.18 beats by $0.13 . Revenue of $1.06B (-10.2% Y/Y) beats by $20M . Adjusted EBITDA of $222 million or 21.0% of Revenue. Net leverage ratio of 5.9x Adjusted EBITDA. Raising...

Second Quarter 2023 Financial Results Revenue of $1,057 million, impacted by an estimated $90-$110 million of revenue related to customer purchasing shifted from the second quarter into the first as a result of ERP system commercial ordering blackout period for legacy Bayer Animal Hea...

2023-08-04 13:15:02 ET Elanco ( NYSE: ELAN ) is scheduled to announce Q2 earnings results on Monday, August 7th, before market open. The consensus EPS Estimate is $0.05 (-86.1% Y/Y) and the consensus Revenue Estimate is $1.04B (-11.6% Y/Y). Over the last 2 years, ELAN ...

2023-07-25 13:21:59 ET Summary Elanco Animal Health Incorporated's share price has declined by 43% over the past year, but the company's raised guidance for 2023 suggests potential for investors. The company has recently been granted a conditional license for the first Canine Parv...